Acomparison between prostaglandin E1 and oxytocin in termination of medical pregnancy (in term pregnancy)
Abstract
Objective:to clear the effect of misoprostol (prostaglandin E1) 50 mcg/4 hours vaginality in induction of labour to terminate pregnancy medically in both primigravide and multigravide in comparison with oxytocin and to concentrate on the complication that may occur during induction .
Methods:our stady is future interventional study . the study took in the labour room of the hospital of tishreen university ,during the period between 2018-2019 . 80 patients were included. Misoprostol 50 mcg vaginality was used for induction of labour in 40 patients . and oxytocin intravenously was used for induction in the other 40 patients.
Results:it was clear from our study that prostaglandin E1 is more effective than oxytocin in induction of labour and termination pregnancy from where succsed induction and reducing the number of cesarean sections .
هدف البحث : معرفة مدى فعالية الميزوبروستول (البروستاغلاندين E1) بجرعة 50مكغ/4 ساعات مهبليا في تحريض المخاض لإنهاء الحمل الطبي لدى الخروسات والولودات بمقارنته مع الأوكسيتوسين وتبيان المضاعفات التي قد تحدث في أثناء التحريض .
الطرائق : أجريت دراسة وهي دراسة تداخلية مستقبلية في قسم المخاض بمستشفى تشرين الجامعي في مدينة اللاذقية خلال 2018-2019 حيث تم تطبيق تحريض إنضاجي (على عنق رحم ناضج ) لدى 80 سيدة مستطب إنهاء الحمل لديهن . استخدم البروستاغلاندين E1(الميزوبروستول ) بجرعة 50مكغ مهبليا عند 40 سيدة ، وطبق الأوكسيتوسين تسريب وريدي لدى 40 سيدة أخرى .
النتائج : تبين من خلال الدراسة أن تطبيق البروستاغلاندين E1 كان ذا نتائج أفضل من تطبيق الأوكسيتوسين في تحريض المخاض وانهاء الحمل من حيث نجاح التحريض ومن حيث إنقاص نسبة القيصريات .
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.